Articles On Telix Pharmaceuticals (ASX:TLX)

ASX rockets 2.56% higher on ceasefire Info tech leads the charge, up 6.44% Energy, utilities, consumer staples continue to retreat as sentiment shifts ASX chows down on TACOs The S&P ASX 200 was eating well today. The market was trea...

Highlights Australian biotech firms advance platelet freezing and medical technologies. Clinical trial progress and regulatory submissions shape sector activity. Healthcare companies reflect innovation across diagnostics and...

Highlights Retail, fashion, and healthcare names attract strong broker attention Operational updates and sector positioning drive interest Growth strategies and resilience remain key focus areas   Three ASX shares across consumer...

Many of Australia's top brokers have been busy adjusting their financial models and recommendations again. This has led to a number of broker notes being released this week. Three ASX shares that brokers have named as buys this week are lis...

Cryopreserver Vitrafy reports initial success in a collaborative study with the US military Cogstate knocks ‘em for six with sales orders Heart play Imricor eyes US paediatric expansion   Cryopreserver Vitrafy Life Sciences (ASX:VFY) has...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) was on form and raced higher following the Easter break. The benchmark index rose 1.75% to 8,728.8 points. Will the market be able to build on this on Wednesday? Here are five things to wat...

Telix Pharmaceuticals Ltd (ASX: TLX) shares have been strong performers over the past month. Since this time in March, the radiopharmaceuticals company's shares are up over 30%. As a comparison, the ASX 200 index is up 1.5% over the same pe...

ASX benchmark surges 1.74% higher with 149/200 stocks rising Info tech leads gains with support from resources and major banks Latest Trump deadline looms, threatening escalation in Iranian conflict ASX sets course for the moon The S&...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 1.55% to 8,712.8 points. Four ASX shares that are rising more than most today are listed below...

Telix Pharmaceuticals Ltd (ASX: TLX) shares have jumped 5.3% higher today to $13.64 a piece. The increase comes off the back of the biopharmaceutical's announcement today confirming revenue growth for the first quarter of FY26. The compa...

CSL and Mayne Pharma are confident of escaping the impact of Donald Trump’s 100% pharma tariff whack Amplia shares swoon on pancreatic cancer trial setback At the small end of the sector, the CEO revolving door keeps spinning.   CSL’s (AS...

Bank of Queensland Ltd (ASX: BOQ), Telix Pharmaceuticals Ltd (ASX: TLX) and NextDC Ltd (ASX: NXT) shares are grabbing headlines today. In late morning trade on Tuesday, all three blue-chip stocks are racing ahead of the 2.6% intraday gains...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are on the move on Tuesday morning. At the time of writing, the radiopharmaceuticals company's shares are up 8.5% to $14.05. Why are Telix shares rising today? Investors have been buying Telix sha...

The Ramelius Resources Ltd (ASX: RMS) share price is in focus after the company delivered 38,093 ounces of gold during the March quarter and confirmed its FY26 production guidance remains on track. What did Ramelius Resources report? Gold...

The Bank of Queensland Ltd (ASX: BOQ) share price is in focus today as BOQ announced a strategic $3.7 billion equipment finance loan sale to Challenger Ltd (ASX: CGF), plus a new 12-month forward flow agreement expected to boost the bank's...

The Guzman y Gomez Ltd (ASX: GYG) share price is in focus today after the Mexican-inspired restaurant chain posted Q3 FY26 sales growth, with network sales up 19.5% to $345.9 million and five new Australian restaurants opening in the quarte...

NEXTDC Ltd (ASX: NXT) share price is in focus after the company announced a $1.0 billion hybrid securities offer, backed by a binding $1.0 billion commitment from Canadian investment group La Caisse, to support ongoing growth. What did NEXT...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus after the company reported group revenue of US$230 million, up 11% quarter-over-quarter, and reaffirmed its FY 2026 revenue guidance. What did Telix Pharmaceuticals report? U...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, April 7, 2026 /PRNewswire/ — Telix Pharmac...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Koala Company (ASX:KOA) ripped out a fairly strong first week on the Australian market after floating on Tuesday, March 31, following an upswing that day with two more bumper jumps to settle ~$4/share into the Easter weekend. Listen to t...

S&P/ASX 200 Health Care Index (ASX: XHJ) shares have tumbled 27% over six months as the sector faces multiple challenges. Blackwattle Large Cap Quality Fund portfolio managers Joe Koh and Elan Miller cite unfavourable currency chang...

It's been a wild ride for this erratic ASX healthcare stock. Telix Pharmaceuticals Ltd (ASX: TLX) surged to $29.72 nearly a year ago, only to crash around 72% to $8.26 in February. In the past month the ASX healthcare stock has clawed i...

The Ides of March weighed down the sector, but green shoots of recovery may make April fools of the naysayers Telix Pharmaceuticals shares led the top end recovery with a 40% gain It’s April – and drug developers with names starting with ‘...

The S&P/ASX 200 Index (ASX: XJO) had a tough month in March due to war breaking out in the Middle East, rising inflation, and higher interest rates. This led to the benchmark index sinking a sizeable 7.8% for the month. Not all shares...

Highlights Healthcare stocks face heightened short-selling activity Sector weakness reflects shifting sentiment and company-specific factors Clinical updates and strategic moves shape outlook across key players Healthcare stocks f...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are charging higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $13.04. In afternoon trade on Tuesday, shares a...

It does not always feel comfortable buying shares when they are down heavily. Prices are falling, headlines are negative, and sentiment is weak.  But in my opinion, this can sometimes be the best time to make a move. A market creat...

Are you looking for ASX shares to buy after this month's market weakness? Well, if you are, let's see what analysts are saying about the popular shares in this article, courtesy of The Bull. Are they buys, holds, or sells? Let's find out:...

China’s NMPA just became the game everyone has to play Audeara cracks into China with NMPA win Big market big upside for companies, but execution decides   For any healthcare company eyeing China, there’s one acronym that controls the ent...

It was a sour end to what has otherwise been a sweet week for ASX investors this Friday. After remaining in red territory all session today, the S&P/ASX 200 Index (ASX: XJO) finished the week with a slight 0.11% loss. As such, we head i...

Putting $20,000 to work in the market is a meaningful step. At that size, I'd be thinking about building a portfolio that can grow through different conditions. For me, that means combining quality, growth, and a bit of resilience. He...

Highlights Analyst confidence rises despite recent weakness Growth-focused sectors draw renewed market attention Volatility continues shaping sentiment across key counters Growth-focused ASX stocks continue to attract attention as...

It's been a rough stretch for some of the most talked-about ASX shares. But here's the twist: while share prices have slid or stalled, broker optimism hasn't. In fact, it's surging. Three ASX shares stand out right now: Mesoblast Ltd (A...

If you are looking to add some ASX 200 stocks to your portfolio this week, it could be worth checking out the two in this article. That's because Bell Potter believes they could be dirt cheap at current levels. Here's what the broker is rec...

Highlights Benchmark index extends its losing streak Resource and banking stocks lead declines Defensive sectors offer limited support The Australian market witnessed extended weakness as multiple sectors faced pressur...

ASX health sector falls 1.85% for the past five days while broader market down  Racura Oncology soars as third and final patient dosed in CPACS Phase I trial  Telix submits new drug application to US FDA for brain cancer imaging agent TLX1...

It's been a wild ride for investors in Telix Pharmaceuticals Ltd (ASX: TLX) shares. The biotech star surged to a high of $29.72 nearly a year ago, only to tumble around 56% to $12.29 at the time of writing. That kind of volatility might...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

The S&P/ASX 200 Index (ASX: XJO) enjoyed another mild recovery day this hump day, adding to yesterday's modest rise. After a brief dip into negative territory this morning, the ASX 200 spent the rest of the day in the green, closing up...

ASX healthcare stocks are a popular option for investors seeking defensive assets with long-term structural growth. These shares can offer portfolio diversification, drive high margins, and some of them have huge potential upside. He...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are racing higher in Wednesday morning trade. At the time of writing the biopharmaceutical company's shares are up 8% to $12.58 a piece. The uptick now means the shares are 11% higher for the y...

Investors caught a break in what was a mildly positive Tuesday session for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares. After starting strong this morning, the ASX 200 took a brief dip into negative territory in afternoon tradi...

Several high-profile ASX shares have taken a beating in recent months. Technology and biotech names have been caught in the market sell-off, with some shares sliding 50% from recent highs. But that weakness has also caught the attention...

At first glance, the Australian share market doesn't look particularly cheap. Even after the recent pullback driven by escalating tensions in the Middle East, the S&P/ASX 200 Index (ASX: XJO) is still sitting not far from record hig...

ASX utilities stock Rivco Australia Ltd (ASX: RIV) is in focus today. The team at Bell Potter have just initiated coverage on it, with a positive outlook.  Company overview Rivco Australia is provides investors with exposure to the A...

Highlights Short interest trends reveal shifting sentiment across several ASX companies Declining bearish positions seen in a few heavily pressured businesses Fresh pessimistic bets emerge in technology, healthcare and servi...

The S&P/ASX 200 Index (ASX: XJO) is out of form on Monday. In afternoon trade, the benchmark index is down 0.5% to 8,573.9 points. Four ASX shares that are falling more than most today are listed below. Here's why they are dropping:...

Highlights Several well-known Australian companies are attracting elevated bearish positioning across the market. Food, technology, healthcare and resource names dominate the latest list. Shifting sentiment highlights how va...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck An additional news report on the recommendation, valuation, forecast...